OR WAIT null SECS
September 16, 2019
Nephron Pharma and the University of South Carolina plan to build a sterile compounding lab at the University for research and training.
September 13, 2019
FDA approved the drug after a successful open-label study of children aged six to 11 years and living with the condition.
September 11, 2019
The company’s Custom Single Run product line now has available bioreactors with working volumes of up to 6000 L.
September 10, 2019
Bayer will use ProBioGen’s GlymaxX technology to maximize the potency of its antibody drug candidate in development for oncological indications.
September 09, 2019
The new antibody, Citryll’s CIT-013, could offer new treatment options for various human diseases including lupus, vasculitis, pulmonary fibrosis, and organ damage due to sepsis.
September 03, 2019
The new facility, located in Ness Ziona, Israel, will support clinical phage manufacturing and can be expanded in the future to support commercial-scale manufacturing.
The joint venture, named BacThera, will operate out of headquarters in Basel, Switzerland and will serve pre-clinical to Phase II projects, with the ability to expand to Phase III and commercial manufacturing in the future.
September 01, 2019
The evolution of cell-culture technology is driving the need for improvements in modeling solutions.
August 30, 2019
A collaboration between Insilico Biotechnology and IFAT aims to develop a manufacturing, planning, and control system for the production of monoclonal antibodies.
August 28, 2019
The partners will collaborate to identify the bioactive components in hydrolysates, which have long been used as additives in cell culture media and feed formulation in the biopharma industry.